Jamieson Wellness (TSE:JWEL) Price Target Raised to C$42.00

Jamieson Wellness (TSE:JWEL) had its target price boosted by TD Securities from C$40.00 to C$42.00 in a report published on Friday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

A number of other analysts also recently weighed in on JWEL. Canaccord Genuity Group upped their target price on Jamieson Wellness from C$32.50 to C$36.25 in a research report on Friday, August 9th. BMO Capital Markets upped their target price on Jamieson Wellness from C$35.00 to C$42.00 in a research report on Friday, August 9th. Finally, Royal Bank of Canada increased their price target on Jamieson Wellness from C$32.00 to C$37.00 in a report on Friday, August 9th.

Jamieson Wellness Stock Performance

Shares of TSE JWEL opened at C$35.76 on Friday. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76. Jamieson Wellness has a 12 month low of C$23.98 and a 12 month high of C$35.90. The stock has a 50 day moving average of C$34.04 and a 200-day moving average of C$30.66. The company has a market capitalization of C$1.48 billion, a P/E ratio of 41.58 and a beta of 0.63.

Insider Buying and Selling at Jamieson Wellness

In other news, Senior Officer Regan Stewart sold 8,732 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of C$31.65, for a total transaction of C$276,373.04. In other Jamieson Wellness news, Director Michael Al Pilato sold 24,465 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of C$33.41, for a total transaction of C$817,380.54. Also, Senior Officer Regan Stewart sold 8,732 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of C$31.65, for a total value of C$276,373.04. Company insiders own 0.26% of the company’s stock.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.